TY - JOUR
T1 - Homocysteine increases during endurance exercise
AU - Herrmann, Markus
AU - Schorr, Heike
AU - Obeid, Rima
AU - Scharhag, Jürgen
AU - Urhausen, Axel
AU - Kindermann, Wilfried
AU - Herrmann, Wolfgang
PY - 2003
Y1 - 2003
N2 - Hyperhomocysteinemia is a risk factor for cardiovascular and other diseases. Recently many endogenous and exogenous modulators of homocysteine (Hcy) have become known, e.g., B-vitamins. However, little is known about the effect of exercise on Hcy. The purpose of this study was to investigate the effect of three different types of acute endurance exercise on serum Hcy. We measured Hcy in 100 recreational athletes (87 males, 13 females) who participated in a marathon race (n = 46), a 100 km run (100 km; n = 12) or a 120 km mountain bike race (n = 42). Blood samples were taken before, 15 min and 3 h after the race. In athletes with pre-race Hcy > 12 μmol/l we also determined folate and vitamin B12. Marathon running induced a Hcy increase of 64%, while mountain biking and 100 km running had no significant effect on Hcy. Pre-race Hcy (25th-75th percentile) overall; marathon race; 100 km; mountain bike race was 9.7 (7.1-11.5) μmol/l; 9.8 (7.4-11.1) μmol/I; 10.2 (6.6-13.2) μmol/I; 9.1 (6.9-13.5) μmol/l, respectively. At 15 min and 3 h post-race, Hcy was 11.9 (8.4-16.4) μmol/l; 16.1 (12.7-20.4) μmol/l; 9.5 (7.8-15.9) μmol/l; 8.8 (7.1-11.2) μmol/l, respectively, and 11.5 (8.9-15.7) μmol/l; 14.9 (11.5-20.0) μmol/l; 10.0 (8.1-11.8) μmol/l; 9.4 (7.4-12.1) μmol/l, respectively. The change in Hcy correlated negatively with the running time. Twenty-three athletes had pre-race Hcy levels > 12 μmol/l, which were associated with relatively low folate (14.3 (11.6-18.9) nmol/l) and vitamin B12 levels (231 (183-261) pmol/l). Endurance exercise may induce a considerable Hcy increase, which varies between different disciplines and is most probably determined by the duration and intensity of exercise. Furthermore, about 25% of recreational endurance athletes exhibited hyperhomocysteinemia in association with low vitamin B12 and folate levels.
AB - Hyperhomocysteinemia is a risk factor for cardiovascular and other diseases. Recently many endogenous and exogenous modulators of homocysteine (Hcy) have become known, e.g., B-vitamins. However, little is known about the effect of exercise on Hcy. The purpose of this study was to investigate the effect of three different types of acute endurance exercise on serum Hcy. We measured Hcy in 100 recreational athletes (87 males, 13 females) who participated in a marathon race (n = 46), a 100 km run (100 km; n = 12) or a 120 km mountain bike race (n = 42). Blood samples were taken before, 15 min and 3 h after the race. In athletes with pre-race Hcy > 12 μmol/l we also determined folate and vitamin B12. Marathon running induced a Hcy increase of 64%, while mountain biking and 100 km running had no significant effect on Hcy. Pre-race Hcy (25th-75th percentile) overall; marathon race; 100 km; mountain bike race was 9.7 (7.1-11.5) μmol/l; 9.8 (7.4-11.1) μmol/I; 10.2 (6.6-13.2) μmol/I; 9.1 (6.9-13.5) μmol/l, respectively. At 15 min and 3 h post-race, Hcy was 11.9 (8.4-16.4) μmol/l; 16.1 (12.7-20.4) μmol/l; 9.5 (7.8-15.9) μmol/l; 8.8 (7.1-11.2) μmol/l, respectively, and 11.5 (8.9-15.7) μmol/l; 14.9 (11.5-20.0) μmol/l; 10.0 (8.1-11.8) μmol/l; 9.4 (7.4-12.1) μmol/l, respectively. The change in Hcy correlated negatively with the running time. Twenty-three athletes had pre-race Hcy levels > 12 μmol/l, which were associated with relatively low folate (14.3 (11.6-18.9) nmol/l) and vitamin B12 levels (231 (183-261) pmol/l). Endurance exercise may induce a considerable Hcy increase, which varies between different disciplines and is most probably determined by the duration and intensity of exercise. Furthermore, about 25% of recreational endurance athletes exhibited hyperhomocysteinemia in association with low vitamin B12 and folate levels.
KW - Folate
KW - Homocysteine
KW - Marathon running
KW - Mountain biking
KW - Physical exercise
KW - Vitamin B
UR - http://www.scopus.com/inward/record.url?scp=0344256727&partnerID=8YFLogxK
U2 - 10.1515/CCLM.2003.233
DO - 10.1515/CCLM.2003.233
M3 - Article
C2 - 14656035
AN - SCOPUS:0344256727
SN - 1434-6621
VL - 41
SP - 1518
EP - 1524
JO - Clinical Chemistry and Laboratory Medicine
JF - Clinical Chemistry and Laboratory Medicine
IS - 11
ER -